M&T Bank Corp Relay Therapeutics, Inc. Transaction History

M&T Bank Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$7.5 - $12.07 $262 - $422	-35 Reduced 0.06%	54,250 $450,000
Q4 2023 Feb 06, 2024	BUY	$6.01 - $11.48 $49,714 - $94,962	8,272 Added 17.98%	54,285 $597,000
Q3 2023 Nov 02, 2023	BUY	$8.24 - $12.97 $120,674 - $189,945	14,645 Added 46.69%	46,013 $386,000
Q2 2023 Aug 09, 2023	BUY	$9.99 - $18.27 $39,700 - $72,604	3,974 Added 14.51%	31,368 $393,000
Q4 2022 Feb 13, 2023	SELL	$14.16 - $24.02 $133,033 - $225,667	-9,395 Reduced 40.5%	13,805 $206,000
Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $192,420 - $326,407	13,589 Added 98.44%	27,394 $409,000
Q3 2022 Nov 14, 2022	SELL	$18.07 - $31.37 $70,509 - $122,405	-3,902 Reduced 14.4%	23,200 $518,000
Q2 2022 Aug 05, 2022	BUY	$13.31 - $34.88 $220,759 - $578,519	16,586 Added 157.72%	27,102 $454,000
Q4 2021 Feb 07, 2022	BUY	$26.0 - $37.03 $70,902 - $100,980	2,727 Added 35.01%	10,516 $323,000
Q3 2021 Oct 28, 2021	BUY	$29.75 - $37.99 $58,280 - $74,422	1,959 Added 33.6%	7,789 $246,000
Q1 2021 May 06, 2021	BUY	$32.52 - $61.53 $22,438 - $42,455	690 Added 13.42%	5,830 $202,000
Q3 2020 Nov 06, 2020	BUY	$32.81 - $45.1 $168,643 - $231,814	5,140 New	5,140 $219,000

203

157M

192K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $507M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.